Albendazole is an anthelmintic medication used to treat parasitic worm infections. Its therapeutic role is to eliminate intestinal and tissue parasites thereby reducing the associated clinical manifestations of infection. The drug is converted intracellularly to its active metabolite oxibendazole a benzimidazole compound that binds to parasite tubulin. This binding interferes with microtubule polymerization halting essential cellular processes in the worm. The disrupted microtubule dynamics lead to death of the parasite while sparing host tissues because the drug preferentially accumulates in the parasite. Consequently the medication is absorbed in the intestine distributed systemically metabolized to an active form and excreted primarily through the liver providing sustained antiparasitic activity.

Albendazole is an anthelmintic medication used to treat various parasitic worm infections. It works by inhibiting the parasite's ability to form microtubules, which are essential for cell division and motility. The drug binds to beta-tubulin in the worm's cells, disrupting the structure of microtubules and preventing energy production. This disruption leads to the death of the adult worms in the gastrointestinal or tissue sites where they reside. By clearing the infection, Albendazole restores normal intestinal function and reduces symptoms such as abdominal discomfort and anemia. Its effectiveness against a broad range of parasites makes it a common choice for both intestinal and systemic helminth infections worldwide.

Albendazole is an oral medication used to treat certain parasitic infections. It is generally well tolerated but can produce side effects in some people. The most frequent adverse reactions include abdominal discomfort and nausea. Headache, dizziness, and fatigue are also reported commonly. Transient elevations of liver enzymes may occur without noticeable symptoms. Skin rash or itching can develop in a minority of patients. In rare cases, visual disturbances such as blurred vision have been described. Most side effects are mild and resolve after discontinuing the drug.

Nausea and vomiting are frequently reported along with abdominal pain and diarrhea. Headache and dizziness may also occur though less commonly. Some patients experience skin reactions such as rash or itching. Fatigue and malaise are reported in a minority of cases. Elevated liver enzymes are occasionally detected in blood tests indicating mild hepatic irritation. Bone marrow suppression can lead to temporary reductions in white blood cell counts though it is relatively uncommon. Allergic responses such as swelling of the face or tongue are rare but have been documented. Most side effects are mild to moderate and typically resolve after discontinuation of the drug.